Stanford V chemotherapy and involved field radiotherapy for children and adolescents with unfavorable risk Hodgkin lymphoma: Results of a multi-institutional prospective clinical trial.Monika L. Metzger, Melissa M. Hudson, Eric Larsen et al.|Journal of Clinical Oncology|2012Cited by 7
Results of a prospective clinical trial for VAMP alone without irradiation for pediatric favorable, early-stage Hodgkin lymphoma patients who achieve an early complete response.Monika L. Metzger, MP Link, Harel Weinstein et al.|Journal of Clinical Oncology|2011Cited by 1
Metabolic-Only Criteria in Pediatric High-Risk (HR) cHL: A Review of Reduced Radiotherapy (RT) Exposure in HLHR13 and cHOD17 TrialsJohn T. Lucas, Matthew J. Ehrhardt, Hesham Elhalawani et al.|Klinische Pädiatrie|2025Cited by 0